Classification
Product TypeIngredient
Product FormBotanical Extract
Industry PositionBotanical Extract Ingredient (Food Supplement / Nutraceutical)
Market
Noni extract (Morinda citrifolia) in the Philippines appears primarily as a niche nutraceutical/food-supplement ingredient and finished-product category regulated under the Philippine FDA framework for food supplements. The Philippine FDA Verification Portal lists a registered liquid noni-extract food supplement product (issuance date September 3, 2025; expiry date September 3, 2027), indicating formal market participation and labeling constraints (e.g., no approved therapeutic claims). Publicly consolidated statistics specific to noni extract production/trade are limited, but local research and corporate activity indicate existence of Philippine-origin extraction/processing capability. Market access and continuity are highly sensitive to regulatory authorization status and compliant claims/labeling for food supplements.
Market RoleNiche domestic food-supplement market with local processing capability; not evidenced as a major global exporter
Domestic RoleFinished food supplements (including liquid noni extract) registered and monitored under Philippine FDA processes
Market Growth
Specification
Primary VarietyMorinda citrifolia (noni)
Physical Attributes- Commercial PH market example includes a liquid noni-extract product registered as a food supplement.
Supply Chain
Value Chain- Raw noni fruit sourcing → washing/sorting → pulping/pressing or extraction → filtration → concentration/standardization → packaging (bulk or retail) → regulatory authorization/labeling control → distribution and/or export shipment
Temperature- Protect finished extract/supplement from excessive heat during storage and transport to reduce quality degradation risk (apply buyer specification).
Shelf Life- Shelf-life depends on formulation and packaging; buyer typically requires lot-level COA and stability/shelf-life substantiation for supplements.
Freight IntensityMedium
Transport ModeSea
Risks
Regulatory Compliance HighFood supplement authorization and claims compliance is a deal-breaker risk in the Philippines: Philippine FDA materials and listings emphasize that regulated health products require proper authorization and that therapeutic claims are not approved for food supplements (e.g., registered noni extract listing explicitly notes no approved therapeutic claims). Non-compliance can trigger enforcement, delisting, import/export restraint requests, and market access disruption.Maintain current Philippine FDA establishment licensing (as applicable) and product authorization; implement label/claims governance so marketing stays within allowed food-supplement positioning; keep a defensible product dossier (spec, COA, traceability) aligned to regulatory and buyer requirements.
Documentation Gap MediumExport clearance delays can occur if Bureau of Customs documentary requirements (e.g., export declaration, invoice, packing list, and any additional port-required documents) are incomplete or inconsistent.Use a pre-shipment documentation checklist mapped to the BOC export workflow and port-of-loading requirements; reconcile product description and quantities consistently across all documents.
Quality MediumBotanical extract quality variability and insufficient standardization/identity testing can lead to buyer rejection or post-market issues, particularly when products are positioned as supplements.Adopt standardized raw-material acceptance and batch-release testing (identity + contaminants + micro limits) with retained samples and lot-level COA.
Logistics MediumSea-freight volatility and handling stress (especially for liquid formats) can erode margins and increase the risk of quality degradation or leakage during transit.Use robust food-grade primary packaging with secondary containment; specify transit temperature/handling requirements in contracts; consider higher-solids concentrate or powder format where feasible to reduce freight exposure.
Standards- HACCP
- ISO 22000
- GMP (supplement manufacturing)
FAQ
Does Philippine FDA registration allow therapeutic disease-treatment claims for noni extract food supplements?No. A Philippine FDA Verification Portal listing for a registered liquid noni extract food supplement explicitly notes it is registered as a food supplement with no approved therapeutic claims, so marketing should avoid therapeutic disease-treatment claims and stay within allowed supplement positioning.
Which Philippine FDA licensing mechanism is relevant for companies acting as exporters of food supplements?Philippine FDA Circular No. 2021-012 describes use of the FDA eServices Portal System for License to Operate (LTO) applications for food traders/distributors, including exporters, covering processed food products and food supplements.
What core documents does the Bureau of Customs list for export processing from the Philippines?The Bureau of Customs export guidelines list submission of an Export Declaration printout, a proforma/commercial invoice, and a packing list, plus other documents as may be required by the BOC, as part of export processing at the port of loading.